- Tytuł:
-
Dose–response effects on HbA
1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial - Autorzy:
- Źródło:
- Diabetologia: Clinical, Translational and Experimental Diabetes and Metabolism. 67(3):470-482
Czasopismo naukowe